Global Epidemiology of Nontuberculous Mycobacterial Pulmonary Disease: A Review

被引:38
|
作者
Prevots, D. Rebecca [1 ]
Marshall, Julia E. [1 ]
Wagner, Dirk [2 ]
Morimoto, Kozo [3 ]
机构
[1] NIAID, Div Intramural Res, Epidemiol & Populat Studies Unit, NIH, 5601 Fishers Lane, Bethesda, MD 20852 USA
[2] Univ Freiburg, Fac Med, Med Ctr, Dept Internal Med 2,Div Infect Dis, Hugstetter St 55, b106, Freiburg, Germany
[3] Fukujuji Hosp, Japan AntiTB Assoc JATA, Div Clin Res, 3-1-24 Matsuyama, Tokyo, Japan
基金
美国国家卫生研究院;
关键词
Epidemiology; Nontuberculous mycobacteria; Mycobacterium avium; Mycobacterium abscessus; Pulmonary disease; Global; Exposome; ENVIRONMENTAL RISK-FACTORS; LUNG-DISEASE; CLINICAL-FEATURES; UNITED-STATES; PUBLIC-HEALTH; RESPIRATORY SPECIMENS; PREVALENCE; AVIUM; INFECTION; TUBERCULOSIS;
D O I
10.1016/j.ccm.2023.08.012
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
NTM-PD and NTM pulmonary isolation are increasing in most countries and regions globally. Isolate-based analysis in several countries indicates distinct trends by NTM species, highlighting the need for more species-specific analyses in NTM epidemiology. Available data regarding spe-cies indicates that MAC continues to predominate in most regions, although in Ontario, Canada, and distinct European countries M kansasii, M xenopi, and M malmoense are found with greater fre-quency. Variation in methods and case definitions limit comparisons across countries and regions. Population-based data including incidence and/ or prevalence are available from North America, Europe, East Asia (Japan, South Korea, and Taiwan), and Queensland, Australia. Studies from Central and South America, Africa, China, the Mid-dle East, and South Asia (India) among patients with suspected TB and MDR-TB are important to document the burden of undiagnosed NTM in this population and ensure appropriate treatment. This highlights the need for enhanced mycobacte-rial laboratory capacity to discriminate between cases of TB and NTM by routine speciation of mycobacterial isolates. Clinical data available from several regions have allowed better charac-terization of the affected populations. Across regions, the majority of cases occur among per -sons aged older than 50 years. In North America and East Asia, the proportion with COPD is typi-cally less than 20%, whereas in Europe, the pro-portion with COPD is higher, above 30% in 9 of 13 studies with this information. Implementation of surveillance systems with standard case definitions is needed to allow for global comparison of prevalence and trends. Cur-rent data where NTM-PD is a notifiable condition have shown the importance and utility of these surveillance data. In particular, timely notification data have allowed inference of the incubation period for infection and disease and have further allowed identification of specific high-risk environ-mental niches and environmental risk factors.
引用
收藏
页码:675 / 721
页数:47
相关论文
共 50 条
  • [1] Epidemiology of Pulmonary Nontuberculous Mycobacterial Disease, Japan
    Namkoong, Ho
    Kurashima, Atsuyuki
    Morimoto, Kozo
    Hoshino, Yoshihiko
    Hasegawa, Naoki
    Ato, Manabu
    Mitarai, Satoshi
    EMERGING INFECTIOUS DISEASES, 2016, 22 (06) : 1116 - 1117
  • [2] The epidemiology of nontuberculous mycobacterial pulmonary disease in the Netherlands
    Schildkraut, Jodie Anne
    Zweijpfenning, Sanne Maria Henriette
    Nap, Martijn
    He, Kun
    Dacheva, Elena
    Overbeek, Jetty
    Tostmann, Alma
    Wertheim, Heiman F. L.
    Hoefsloot, Wouter
    van Ingen, Jakko
    ERJ OPEN RESEARCH, 2021, 7 (03)
  • [3] The Epidemiology of Pulmonary Nontuberculous Mycobacterial Disease in Japan
    Namkoong, Ho
    Kurashima, Atsuyuki
    Morimoto, Kozo
    Hoshino, Yoshihiko
    Manabu, Ato
    Mitarai, Satoshi
    Hasegawa, Naoki
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [4] THE EPIDEMIOLOGY OF NONTUBERCULOUS MYCOBACTERIAL DISEASE
    OBRIEN, RJ
    CLINICS IN CHEST MEDICINE, 1989, 10 (03) : 407 - 418
  • [5] A narrative review of nontuberculous mycobacterial pulmonary disease: microbiology, epidemiology, diagnosis, and management challenges
    Hamed, Kamal A.
    Tillotson, Glenn
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2023, 17 (11) : 973 - 988
  • [6] Nontuberculous mycobacterial pulmonary disease
    Johnson, Margaret M.
    Waller, Ernest Andrew
    Leventhal, Jack P.
    CURRENT OPINION IN PULMONARY MEDICINE, 2008, 14 (03) : 203 - 210
  • [7] Nontuberculous mycobacterial pulmonary disease
    Ringshausen, F. C.
    Rademacher, J.
    INTERNIST, 2016, 57 (02): : 142 - 151
  • [8] Nontuberculous mycobacterial lung disease epidemiology in Taiwan: A systematic review
    Lee, Meng-Rui
    Chang, Lih-Yu
    Ko, Jen-Chung
    Wang, Hao-Chien
    Huang, Yi-Wen
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2020, 119 : S4 - S12
  • [9] Epidemiology of nontuberculous mycobacterial pulmonary disease in Europe and Japan by Delphi estimation
    Schildkraut, Jodie A.
    Gallagher, Jack
    Morimoto, Kozo
    Lange, Christoph
    Haworth, Charles
    Floto, R. Andres
    Hoefsloot, Wouter
    Griffith, David E.
    Wagner, Dirk
    van Ingen, Jakko
    RESPIRATORY MEDICINE, 2020, 173
  • [10] Epidemiology of Adults and Children Treated for Nontuberculous Mycobacterial Pulmonary Disease in Japan
    Izumi, Kiyohiko
    Morimoto, Kozo
    Hasegawa, Naoki
    Uchimura, Kazuhiro
    Kawatsu, Lisa
    Ato, Manabu
    Mitarai, Satoshi
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2019, 16 (03) : 341 - 347